Supplemental: Timing of cutaneous immune-related adverse events impacts survival in cancer patients 3 treated with immune-checkpoint inhibitors: A multi-institutional cohort study

Name: Supplemental: Timing of cutaneous immune-related adverse events impacts survival in cancer patients 3 treated with immune-checkpoint inhibitors: A multi-institutional cohort study
Creator: Hannah Rashdan
Published: 2024-01-22T08:47:52.993Z
Keywords: Cancer Immunotherapy, Adverse Effect of Drug

Rashdan, Hannah; Zhang, Shijia; Wan, Guihong; Nguyen, Nga; roster, katier; Rajeh, Ahmad; Tang, Kimberly; Chen, Wenxin; Moseley, Cameron; Chen, Steven

doi:10.17632/fdvcpx6vc3.1

Supplemental: Timing of cutaneous immune-related adverse events impacts survival in cancer patients 3 treated with immune-checkpoint inhibitors: A multi-institutional cohort study

Published: 22 January 2024| Version 1 | DOI: 10.17632/fdvcpx6vc3.1

Contributors:

Hannah Rashdan, Shijia Zhang, Guihong Wan, Nga Nguyen, katier roster, Ahmad Rajeh, Kimberly Tang, Wenxin Chen, Cameron Moseley, Steven Chen

Description

Supplemental for Timing of cutaneous immune-related adverse events impacts survival in cancer patients 3 treated with immune-checkpoint inhibitors: A multi-institutional cohort study

Supplemental: Timing of cutaneous immune-related adverse events impacts survival in cancer patients 3 treated with immune-checkpoint inhibitors: A multi-institutional cohort study

Description

Files

Categories

Licence